General Information:
Id: | 580 (click here to show other Interactions for entry) |
Diseases: |
Alzheimer disease
- [OMIM]
|
Mus musculus | |
brain | |
article | |
Reference: | Phiel CJ et al.(2003) GSK-3alpha regulates production of Alzheimers disease amyloid-beta peptides Nature 423: 435-439 [PMID: 12761548] |
Interaction Information:
Comment | Therapeutic concentrations of lithium block the production of amyloid beta peptides. |
Formal Description Interaction-ID: 3095 |
|
Drugbank entries | Show/Hide entries for Lithium |
Comment | Therapeutic concentrations of lithium block the production of amyloid beta peptides. |
Formal Description Interaction-ID: 3096 |
drug/chemical compound decreases_quantity of gene/protein |
Drugbank entries | Show/Hide entries for Lithium |
Comment | Gamma-secretase affects the APP processing. |
Formal Description Interaction-ID: 3104 |
|
Comment | Overexpression of beta-catenin did not affect amyloid beta peptide (Abeta) production (under conditions that activated the beta-catenin-dependent reporter). |
Formal Description Interaction-ID: 3136 |
gene/protein NOT affects_quantity of gene/protein |
Drugbank entries | Show/Hide entries for CTNNB1 |